Related Experiment Video

Updated: May 8, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

Endocrine manifestations and management of Prader-Willi syndrome

Jill E Emerick1, Karen S Vogt

  • 1Department of Pediatrics, Walter Reed National Military Medical Center Bethesda, 8901 Wisconsin Ave, Bethesda, MD 20889, USA. Karen.S.Vogt.mil@health.mil.

International Journal of Pediatric Endocrinology
|August 22, 2013
PubMed

Insights

Prader-Willi syndrome (PWS) is a genetic disorder affecting chromosome 15. Early diagnosis and management of endocrine and behavioral issues are crucial for improving health and developmental outcomes in children with PWS.

Area of Science:

  • Genetics
  • Endocrinology
  • Pediatrics

Background:

  • Prader-Willi syndrome (PWS) is a complex genetic disorder due to the absence of paternally expressed genes on chromosome 15q11.2-q13.
  • Infantile hypotonia and failure to thrive evolve into developmental delay, cognitive disability, and behavioral issues in older children.
  • Hypothalamic dysfunction in PWS contributes to hyperphagia, temperature dysregulation, sleep disturbances, and endocrine abnormalities.

Purpose of the Study:

  • To review recent literature on optimal screening and treatment of endocrine abnormalities in PWS.
  • To provide an update on nutritional and behavioral interventions for food-related issues.
  • To emphasize the importance of early diagnosis and comprehensive management for improved outcomes.

Main Methods:

  • Literature review of recent studies on PWS endocrine abnormalities, nutrition, and behavior.
  • Summarization of current standards of care for growth hormone therapy, adrenal insufficiency, hypogonadism, hypothyroidism, and diabetes.
  • Inclusion of screening recommendations and potential side effect surveillance.

Main Results:

  • Growth hormone deficiency, central adrenal insufficiency, hypogonadism, hypothyroidism, and obesity-related complications like type 2 diabetes mellitus are common endocrine issues in PWS.
  • Optimal screening and treatment protocols for these endocrine abnormalities are discussed.
  • Nutrition and behavioral interventions are highlighted as key components of PWS management.

Conclusions:

  • Early diagnosis and meticulous management of endocrine and behavioral manifestations in PWS significantly improve health and developmental trajectories.
  • The role of healthcare providers in the comprehensive care of individuals with PWS is critical.
  • Adherence to established standards of care can mitigate complications and enhance quality of life.

More Related Videos

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

A Modified Technique for Inducing Polycystic Ovary Syndrome in Mice04:49

A Modified Technique for Inducing Polycystic Ovary Syndrome in Mice

Published on: July 5, 2024

Related Concept Videos

Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...